Le Lézard
Classified in: Health
Subjects: SVY, SCZ

New Report from Together Senior Health Addresses Missed Opportunities and Disconnects in Dementia Care


Estimates show that by 2025, more than 12 million Americans will be diagnosed with Alzheimer's Disease and Dementia ? costing health plans more than $345 billion annually.

SAN FRANCISCO, June 14, 2023 /PRNewswire/ -- Together Senior Health, a digital therapeutics and brain health company, has announced the release of a new market report that provides exclusive insight on missed opportunities, clinical disconnects and surging costs of Alzheimer's disease and related dementias (ADRD).

The report "Disconnects in Dementia Care: Opportunities for Impact," is based on findings from an independent survey of 53 national Medicare Advantage health plan leaders that was conducted in March 2023 by healthcare consultancy Sage Growth Partners.

The survey revealed that despite recognizing the health and social impact, many organizations are moving very slowly, or in some cases not at all, to better manage and care for those with ADRD. The report also prominently identifies the disconnect between plans' interest in solutions and the lack of investment in new evidence-based solutions, and also includes recommendations on how health plans can better manage the current and future impact of these costly and debilitating diseases.

"Dementia is a costly and frightening condition, and until recently there have been few evidence-based approaches to managing it," said Cynthia Benjamin, CEO and co-founder, Together Senior Health. "While breakthrough drugs remain out of reach, other therapeutic interventions are demonstrating clinical benefits and cost savings. Focusing on comprehensive, whole-person care will help to reduce high-cost healthcare events and increase the quality of life for those impacted by ADRD."

Key findings of the report include:

"Health plans are relying on primary care providers and family caregivers to manage these members," said Benjamin. "But most are unprepared to screen or care for patients with ADRD and have little to offer given traditional treatment modalities. Providers and patients are excited to utilize new evidence-based solutions that companies like Together Senior Health are bringing to market." 

 Alzheimer's disease and related dementias represent a rising and largely unchecked threat to our nation's healthcare system.

"Much about ADRD remains a mystery and methods for slowing or reversing their progression have been elusive," said Dan D'Orazio, CEO, Sage Growth Partners. "By 2050, the yearly cost to care for ADRD is estimated to reach $1 trillion. This is an immense tally that does not even account for the large price tags of emerging pharmaceuticals. Our research shows that this is an unsustainable scenario that is largely underestimated by our health plans."

To request a complete copy of the report please visit togetherseniorhealth.com

About Together Senior Health
Together Senior Health is a digital therapeutics and brain health company founded by brain scientists, therapists, and changemakers to create better health outcomes for people living with memory loss, Alzheimer's, dementia and cognitive decline. Together Senior Health's integrated solution combines over 15 years of clinical evidence, real-world user experience and engaging, community-based programming. The company partners with Medicare Advantage health insurance plans and other risk bearing healthcare organizations to carry out its vision and impact. Together Senior Health is collaborating with leading institutions like the National Institute of Health (NIH) and the University of California, San Francisco (UCSF) to advance new field research in cognitive health. To learn more, visit togetherseniorhealth.com

For More Information
John Gonda
616-309-4888
[email protected]

SOURCE Together Senior Health


These press releases may also interest you

at 05:44
United Breast Cancer Foundation (UBCF) is turning unwanted cars, trucks, and motorcycles into vehicles for change. Ditch the stress of selling your old set of wheels and donate it to UBCF instead. You'll clear out some garage space, receive a max tax...

at 05:42
Swedish Orphan Biovitrum AB (publ) (Sobi®) has successfully completed the inaugural issue of senior unsecured bonds of SEK 3 billion under its newly established MTN programme. The bonds are divided into three tranches where SEK 1.35 billion was...

at 05:05
TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Alan Sandler, M.D., to its Scientific Advisory Board (SAB). Dr. Sandler, a leading expert in oncology research and pharmaceutical development, was most recently Chief Medical...

at 04:46
Sobi® today announced that the European Commission (EC) has approved an indication extension for Aspaveli® (pegcetacoplan) for treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia. Aspaveli is...

at 03:37
Chamlion, a gamechanging force in the digitalization of dentistry, is set to captivate attendees at the International Dental Equipment Exhibition (IDEX) 2024 in Turkey. With a comprehensive display of integrated dental 3D printing solutions,...

at 03:05
Dr. Clauder's has joined forces with protein pioneer Calysta to launch the world's first dog treats made with FeedKind® Pet protein, a revolutionary new pet food ingredient. Announced at the world's leading pet trade fair, Interzoo, the...



News published on and distributed by: